news

View the latest news and press releases from Xevant

Xevant Expands Ivim at Work and Introduces New Lower Pricing on Wegovy® and Ozempic® for Employers Nationwide

LEHI, Utah–(BUSINESS WIRE)–Xevant today announced expanded access to new, lower pricing for its employer-focused medical weight-loss program, Ivim at Work, significantly reducing the cost of GLP-1 therapy for self-funded employers, brokers, and PBMs. The enhanced pricing structure is fully optimized through Xevant’s VerX platform, which identifies and delivers the lowest-cost, clinically appropriate options across the pharmacy ecosystem.

Read More

Xevant Expands VerX Platform, Delivering AI-Driven Pharmacy Cost Optimization in the Emerging RxTech Era

LEHI, Utah–(BUSINESS WIRE)–Xevant today announced major advances to its VerX™ Platform, unveiling a new set of interconnected systems — Cortex, Pulse, Axis, and Nudge — that together demonstrate the operational reality of RxTech, the emerging technology segment transforming pharmacy benefits to eliminate more than $250 billion in prescription waste and deliver the lowest net cost for medications.

Read More

Xevant White Paper Highlights Opportunities for Transparency in PBM Model, Introduces VerX as Breakthrough for Cost Optimization

LEHI, Utah — September 22, 2025 — Xevant, a leader in pharmacy benefits analytics, today announced the release of a new white paper: “Cracking Open the PBM Black Box: Unlocking Transparency and Partnership with VerX.” The report explores the challenges faced by traditional pharmacy benefit manager (PBM) models and highlights how VerX is helping plan […]
Read More

Xevant Releases New eBook Uncovering the Top 4 PBM Trends Reshaping Pharmacy Benefits in 2025

AI-powered insights reveal industry shifts in drug cost management, transparency, and access for PBMs, brokers, consultants, TPAs, health plans, and employers.

LEHI, Utah–(BUSINESS WIRE)–Xevant, a leader in AI-driven pharmacy benefits optimization, today announced the release of its latest eBook: Top 4 PBM Trends to Watch in 2025 and Beyond. The publication explores four critical trends that are transforming the pharmacy benefits landscape and offers timely strategies for pharmacy benefit managers, brokers, benefits consultants, health plan executives, TPAs, and self-insured employers.

Read More

Xevant Launches VerX: A Bold Strike Against the Rx Cost Crisis

LEHI, Utah–(BUSINESS WIRE)–Xevant, a leader in real-time pharmacy benefits AI and analytics, today announced the launch of VerX (pronounced “Vair-ex”), a powerful new platform that redefines how pharmacy benefits are optimized, managed, and controlled. VerX is the first platform to crack open the black box of pharmacy benefits by reverse engineering prescription claims to reveal the lowest achievable net cost for every claim, in real time.

Read More

Ivím at Work, Offered by Ivím Health and Xevant, Named Gold Stevie® Award Winner in 2025 American Business Awards®

LEHI, Utah–(BUSINESS WIRE)–Ivím at Work, a joint solution from Ivím Health and Xevant, has been named the winner of the Gold Stevie® Award in the Consumer Products category in the 23rd Annual American Business Awards®. The American Business Awards are the premier business awards program in the U.S., open to public and private, for-profit and nonprofit organizations of all sizes.

Read More

Xevant Unveils 2025 Drug Price Inflation White Paper: A Data-Driven Look at Rising Pharmaceutical Costs and Future Implications

LEHI, Utah, April 25, 2025–(BUSINESS WIRE)–Xevant, a leading provider of real-time data analytics for pharmacy benefit management, today announced the release of its 2025 Drug Price Inflation White Paper, providing key insights into the ongoing surge in pharmaceutical prices and what it means for payers, employers, and pharmacy benefit managers (PBMs).

Read More

Xevant Introduces the All-New Biosimilar Dashboard, A Real-Time Analytics Tool to Accelerate Biosimilar Adoption and Reduce Unnecessary Biologic Drug Spend

A First-of-Its-Kind Tool Empowering Healthcare Stakeholders to Accelerate Biosimilar Adoption and Reduce Unnecessary Biologic Drug Spend. LEHI, Utah–(BUSINESS WIRE)–Xevant, a leader in pharmacy benefits automation, today announces the launch of its all-new Biosimilar Dashboard, a real-time analytics tool designed to streamline biosimilar adoption and reduce unnecessary spending on biologic drugs. “The Biosimilar Dashboard provides the […]
Read More

Xevant Announces New E-Book: Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers

LEHI, Utah–(BUSINESS WIRE)–As obesity rates in the United States have reached 41.9 percent among adults, Xevant has released a new e-book, Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers, designed to empower employers with the tools and insights needed to address this critical health and economic challenge. The e-book offers actionable guidance on crafting effective, sustainable corporate weight management […]
Read More

Xevant Enhances Automated Analytics Platform with AI to Revolutionize Healthcare Data Ingestion and Standardization

Xevant’s new AI-powered capabilities streamline data ingestion and pave the way for transformative improvements in pharmacy cost management for PBM stakeholders. LEHI, Utah–(BUSINESS WIRE)–Xevant, a leader in automated analytics for the pharmacy benefits industry, today announced the launch of new AI-powered capabilities designed to revolutionize the ingestion and standardization of healthcare data.

Read More

Ready to get started?